I liked the line further down the page
"With the recent increased interest in biotech stocks led by stunning gains by Mesoblast and Prima Biomed, Phosphagenics are every chance to be the next biotech to be re-rated".
- Forums
- ASX - By Stock
- marketing is the key to poh growth
I liked the line further down the page "With the recent...
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.783K | 594.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
60 | 96365901 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 21872826 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 96365901 | 0.002 |
23 | 71850508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 21872826 | 7 |
0.004 | 24583537 | 22 |
0.005 | 27709765 | 14 |
0.006 | 19365067 | 10 |
0.007 | 9365221 | 8 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
AVE (ASX) Chart |